Biotechnology argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia May 5, 2022
Biotechnology Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Tops Revenue Estimates May 4, 2022
Biotechnology Ascendis Pharma A/S Announces First Quarter 2022 Financial Results and Business Update Conference Call on May 11 May 4, 2022
Search
biotech stock market
